105 related articles for article (PubMed ID: 21196797)
1. Incidental resolution of a radiation-induced cavernous hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma.
Aguilera D; Tomita T; Goldman S; Fangusaro J
Pediatr Neurosurg; 2010; 46(4):303-7. PubMed ID: 21196797
[TBL] [Abstract][Full Text] [Related]
2. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
Osumi AK; Mclendon RE; Tien RD; Friedman HS; Graham M; Hockenberger B; Halperin EC; Oakes WJ
Clin Neuropathol; 1994; 13(5):281-5. PubMed ID: 7805312
[TBL] [Abstract][Full Text] [Related]
3. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
Mahajan D; Miller C; Hirose K; McCullough A; Yerian L
J Hepatol; 2008 Nov; 49(5):867-70. PubMed ID: 18814928
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors.
Strenger V; Sovinz P; Lackner H; Dornbusch HJ; Lingitz H; Eder HG; Moser A; Urban C
Strahlenther Onkol; 2008 May; 184(5):276-80. PubMed ID: 18427759
[TBL] [Abstract][Full Text] [Related]
5. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
6. Urgent radiotherapy is effective in the treatment of metastatic medulloblastoma causing symptomatic brainstem edema.
Shapiro RH; Chang AL
Pediatr Blood Cancer; 2011 Dec; 57(6):1077-80. PubMed ID: 21755588
[TBL] [Abstract][Full Text] [Related]
7. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.
Lew SM; Morgan JN; Psaty E; Lefton DR; Allen JC; Abbott R
J Neurosurg; 2006 Feb; 104(2 Suppl):103-7. PubMed ID: 16506497
[TBL] [Abstract][Full Text] [Related]
8. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
10. Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse.
Balter-Seri J; Mor C; Shuper A; Zaizov R; Cohen IJ
Cancer; 1997 Mar; 79(6):1241-7. PubMed ID: 9070504
[TBL] [Abstract][Full Text] [Related]
11. Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Nygaard R; Kivivuori SM
Anticancer Drugs; 2012 Mar; 23(3):342-6. PubMed ID: 22156796
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab and stereotactic radiosurgery achieved complete response for pediatric recurrent medulloblastoma.
Zhao M; Wang X; Fu X; Zhang Z
J Cancer Res Ther; 2018 Sep; 14(Supplement):S789-S792. PubMed ID: 30249905
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
Packer RJ
Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
[TBL] [Abstract][Full Text] [Related]
14. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
Paulino AC; Mazloom A; Teh BS; South M; Okcu MF; Su J; Butler EB; Chintagumpala M
Cancer; 2011 Feb; 117(3):635-41. PubMed ID: 20845476
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
16. Electromagnetic navigation-guided neuroendoscopic removal of radiation-induced intraforniceal cavernoma as a late complication of medulloblastoma treatment.
Liby P; Zamecnik J; Kyncl M; Zackova J; Tichy M
Childs Nerv Syst; 2017 Nov; 33(11):2051-2055. PubMed ID: 28689346
[TBL] [Abstract][Full Text] [Related]
17. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
Kellie SJ; Chaku J; Lockwood LR; O'Regan P; Waters KD; Wong CK;
Eur J Cancer; 2005 Jul; 41(11):1588-96. PubMed ID: 16026694
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.
Aguilera DG; Goldman S; Fangusaro J
Pediatr Blood Cancer; 2011 Mar; 56(3):491-4. PubMed ID: 21072819
[TBL] [Abstract][Full Text] [Related]
19. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
20. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
